What does CUSIP 03969F109 represent in this 13F holders report?

CUSIP 03969F109 is the security identifier for RCUS - Arcus Biosciences, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held RCUS - Arcus Biosciences, Inc. - Common Stock in Q2 2018?

61 institutional investors reported RCUS - Arcus Biosciences, Inc. - Common Stock for Q2 2018. Use the holders table for investor-level position and value details.

Arcus Biosciences, Inc. - Common Stock (RCUS)

CUSIP: 03969F109

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock
Shares outstanding: 122,470,452
Total 13F shares: 22,392,855
Share change: +2,692,543
Total reported value: $274,091,081
Price per share: $12.24
Number of holders: 61
Value change: +$31,576,470
Number of buys: 39
Number of sells: 32

Quarterly Holders Quick Answers

What is CUSIP 03969F109?
CUSIP 03969F109 identifies RCUS - Arcus Biosciences, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 03969F109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RCUS - Arcus Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Alphabet Inc.	13F	Company	4.1%	5,049,786	$77,969,000	—	31 Mar 2018	13F
Foresite Capital Management III, LLC	13F	Company	2.8%	3,445,461	$42,080,000	—	31 Mar 2018	13F
EcoR1 Capital, LLC	13F	Company	1.8%	2,236,387	$34,530,000	—	31 Mar 2018	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.7%	2,116,945	$32,216,000	—	31 Mar 2018	13F
BVF INC/IL	13F	Company	1%	1,269,788	$19,606,000	—	31 Mar 2018	13F
PFM Health Sciences, LP	13F	Company	0.76%	933,286	$14,410,000	—	31 Mar 2018	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.54%	655,438	$10,120,000	—	31 Mar 2018	13F
Foresite Capital Management IV, LLC	13F	Company	0.53%	650,000	$10,036,000	—	31 Mar 2018	13F
Board of Trustees of The Leland Stanford Junior University	13F	Company	0.51%	625,062	$9,651,000	—	31 Mar 2018	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.38%	468,587	$7,235,000	—	31 Mar 2018	13F
HILLHOUSE INVESTMENT MANAGEMENT, LTD.	13F	Company	0.35%	425,000	$6,562,000	—	31 Mar 2018	13F
LORD, ABBETT & CO. LLC	13F	Company	0.25%	300,694	$4,643,000	—	31 Mar 2018	13F
Artal Group S.A.	13F	Company	0.24%	300,000	$4,632,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.17%	205,941	$3,180,000	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.11%	129,025	$1,992,000	—	31 Mar 2018	13F
Marshall Wace North America L.P.	13F	Company	0.08%	103,854	$1,604,000	—	31 Mar 2018	13F
JBF Capital, Inc.	13F	Company	0.08%	100,000	$1,544,000	—	31 Mar 2018	13F
Alyeska Investment Group, L.P.	13F	Company	0.07%	85,000	$1,312,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	0.05%	60,000	$927,000	—	31 Mar 2018	13F
Laurion Capital Management LP	13F	Company	0.05%	60,000	$926,000	—	31 Mar 2018	13F
FIL Ltd	13F	Company	0.04%	53,286	$823,000	—	31 Mar 2018	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.04%	50,150	$774,000	—	31 Mar 2018	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.03%	41,652	$643,107	—	31 Mar 2018	13F
ELEMENT CAPITAL MANAGEMENT LLC	13F	Company	0.03%	34,990	$540,000	—	31 Mar 2018	13F
NORGES BANK	13F	Company	0.02%	30,000	$463,000	—	31 Mar 2018	13F
TD ASSET MANAGEMENT INC	13F	Company	0.02%	29,258	$452,000	—	31 Mar 2018	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.02%	27,723	$428,000	—	31 Mar 2018	13F
WOLVERINE ASSET MANAGEMENT LLC	13F	Company	0.02%	25,000	$386,000	—	31 Mar 2018	13F
BlueCrest Capital Management Ltd	13F	Company	0.02%	20,474	$316,000	—	31 Mar 2018	13F
BlackRock Finance, Inc.	13F	Company	0.02%	19,649	$303,000	—	31 Mar 2018	13F
DC Investments Management, LLC	13F	Company	0.02%	19,617	$303,000	—	31 Mar 2018	13F
Tibra Equities Europe Ltd	13F	Company	0.01%	17,920	$277,000	—	31 Mar 2018	13F
HBK INVESTMENTS L P	13F	Company	0.01%	15,000	$232,000	—	31 Mar 2018	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	0.01%	11,422	$176,000	—	31 Mar 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	10,010	$155,000	—	31 Mar 2018	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.01%	10,000	$154,000	—	31 Mar 2018	13F
Zimmer Partners, LP	13F	Company	0.01%	10,000	$154,000	—	31 Mar 2018	13F
Cubist Systematic Strategies, LLC	13F	Company	0.01%	8,896	$137,000	—	31 Mar 2018	13F
Monashee Investment Management LLC	13F	Company	0.13%	154,750	$132,000	—	31 Mar 2018	13F
Point72 Hong Kong Ltd	13F	Company	0.01%	7,656	$118,000	—	31 Mar 2018	13F
DAFNA Capital Management LLC	13F	Company	0.01%	7,500	$116,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	0%	6,003	$93,000	—	31 Mar 2018	13F
Partner Investment Management, L.P.	13F	Company	0%	5,698	$88,000	—	31 Mar 2018	13F
AMUNDI ASSET MANAGEMENT US, INC.	13F	Company	0%	4,445	$69,000	—	31 Mar 2018	13F
CITIGROUP INC	13F	Company	0%	3,000	$46,000	—	31 Mar 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	2,562	$40,000	—	31 Mar 2018	13F
Lumina Fund Management LLC	13F	Company	0%	2,550	$39,000	—	31 Mar 2018	13F
CIBC Private Wealth Group LLC	13F	Company	0%	1,500	$23,000	—	31 Mar 2018	13F
Financial Architects, Inc	13F	Company	0%	1,200	$19,000	—	31 Mar 2018	13F
JPMORGAN CHASE & CO	13F	Company	0%	1,100	$17,000	—	31 Mar 2018	13F

Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q2 2018

As of 30 Jun 2018, Arcus Biosciences, Inc. - Common Stock (RCUS) was held by 61 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,392,855 shares. The largest 10 holders included Alphabet Inc., WELLINGTON MANAGEMENT GROUP LLP, Foresite Capital Management III, LLC, EcoR1 Capital, LLC, BVF INC/IL, Partner Fund Management, L.P., Hillhouse Capital Management, Ltd., PRICE T ROWE ASSOCIATES INC /MD/, Board of Trustees of The Leland Stanford Junior University, and JANUS HENDERSON GROUP PLC. This page lists 61 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Q2 2018 holders

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.